Deciphering the metabolome in Alzheimer’s disease

Molecular Neurodegeneration · Published 2026-07-31 · DOI 10.1186/s13024-026-00982-w

Free full text

Authors (2)

Xiaoli Yang, Yong Shen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, X., Shen, Y. (2026). Deciphering the metabolome in Alzheimer’s disease. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-026-00982-w

Related articles

• Mitochondria transfer in neurological disorders: the key role of neuroglia · Molecular Neurodegeneration · 2026 · Same journal
• AQP4-dependent enhancement of glymphatic function attenuates tau pathology and neurodegeneration in PS19 mice · Molecular Neurodegeneration · 2026 · Same journal
• Plasma platelet-derived growth factor receptor-β decrease correlates with blood-brain barrier damage in Alzheimer’s disease · Molecular Neurodegeneration · 2026 · Same journal
• Lipid alterations in hereditary peripheral neuropathies: common mechanisms in disease heterogeneity? · Molecular Neurodegeneration · 2026 · Same journal
• Plasma proteomic signatures of preclinical Alzheimer’s disease in clinically unimpaired older adults · Molecular Neurodegeneration · 2026 · Same journal
• Phospho-ubiquitin: rewriting the ubiquitin code · Molecular Neurodegeneration · 2026 · Same journal
• Systemic complement factors in aging, Alzheimer’s disease and other dementias: a longitudinal study over 10 years · Molecular Neurodegeneration · 2026 · Same journal
• Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes · Molecular Neurodegeneration · 2026 · Same journal
• Transplantation of human iPSC-derived microglia ameliorates neuropathology and circuit dysfunction in progranulin-deficient mice · Molecular Neurodegeneration · 2026 · Same journal
• Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss · Molecular Neurodegeneration · 2026 · Same journal